Last Update Time:
19-Mar-2025 16:00:00
ISIN:
INE579C01029
Sector:
Healthcare
Symbol:
VIMTALABS
Vimta Labs Limited
₹1,075.00
₹-29.55
(-2.68%)
▼
Prev. Close
₹1,104.55
Open
₹1,104.65
Close
₹1,072.95
Range
₹1,021.25 - ₹1,128.75
High
₹1,110.05
Low
₹1,063.30
Ind. Close
₹0.00
VWAP
₹1,087.19
The current stock price of Vimta Labs Limited is ₹1,075.00, with a target price range between ₹1,021.25 and ₹1,128.75. The stock has experienced a price change of ₹-29.55 (-2.68%), reflecting recent market volatility.
Today's opening price was ₹1,104.65, while the previous close stood at ₹1,104.55.
The market trend suggests a potential downtrend, with investors exercising caution due to recent declines. Analysts recommend closely monitoring support levels.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Vimta Labs Limited Price Chart
Vimta Labs Limited Pre Open Market Overview: 19-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 1104.65
- Previous Close Price: 1104.55
- Change: 0.10%
- Total Traded Volume: 423
- Total Buy Quantity: 4,586
- Total Sell Quantity: 10,996
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 1,095.00 | 12.00 | 0.00 |
| 1,096.00 | 5.00 | 0.00 |
| 1,100.00 | 2.00 | 0.00 |
| 1,104.55 | 20.00 | 0.00 |
| 1,104.65 | 66.00 | 0.00 |
| 1,105.00 | 0.00 | 1.00 |
| 1,107.50 | 0.00 | 1.00 |
| 1,108.90 | 0.00 | 300.00 |
| 1,110.00 | 0.00 | 12.00 |
| 1,112.50 | 0.00 | 1.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 4586
Total Sell Quantity: 10996
Shareholding Patterns of Vimta Labs Limited
Key Trade Statistics of Vimta Labs Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 1.23 |
| Traded Value (₹ Cr.) | 13.43 |
| Total Market Cap (₹ Cr.) | 2,388.95 |
| Free Float Market Cap (₹ Cr.) | 787.64 |
| Impact cost | 0.15 |
| Quantity Traded | 123,490.00 |
| Deliverable Quantity | 61,669.00 |
| % of Quantity to Traded | 49.94 |
| Security VaR | 23.42 |
| Index VaR | N/A |
| VaR Margin | 23.42 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 26.92 |
| Face Value | 2 |
Key Price Statistics of Vimta Labs Limited
The 52-week high for Vimta Labs Limited was ₹1,178.00, recorded on 12-Feb-2025. On the other hand, the 52-week low stands at ₹420.00, with the lowest value recorded on 04-Jun-2024.
The upper band for trading is ₹1,325.45, and the lower band is ₹883.65. The price band is 20%.
The stock's daily volatility stands at 3.51, while the annualized volatility is 67.06. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (12-Feb-2025) | 1,178.00 |
| 52 Week Low (04-Jun-2024) | 420.00 |
| Upper Band | 1,325.45 |
| Lower Band | 883.65 |
| Price Band (%) | 20 |
| Daily Volatility | 3.51 |
| Annualised Volatility | 67.06 |
| Tick Size | 0.05 |
Key Securities Statistics of Vimta Labs Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 15-Dec-2005 |
| Adjusted P/E | 41.49 |
| Symbol P/E | 41.49 |
| Index | NA |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Basic Industry | Healthcare Research Analytics & Technology |
Security Status of Vimta Labs Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Vimta Labs Limited
| Subject | Date |
|---|---|
| Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent | 05-Mar-2025 |
| Appointment | 05-Mar-2025 |
| Price movement | 12-Feb-2025 |
| Price movement | 11-Feb-2025 |
| Alteration Of Capital and Fund Raising-XBRL | 11-Feb-2025 |
| Allotment of Securities | 11-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 10-Feb-2025 |
| Copy of Newspaper Publication | 25-Jan-2025 |
Corporate Actions of Vimta Labs Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 2 | Annual General Meeting/Dividend - Rs 2 Per Share | 11-Jul-2024 |
| 2 | Annual General Meeting/Dividend - Rs 2 Per Share | 21-Jun-2023 |
| 2 | Annual General Meeting/Dividend - Rs 2 Per Share | 16-Jun-2022 |
| 2 | Annual General Meeting/Dividend - Rs 2 Per Share | 25-Jun-2021 |
| 2 | Annual General Meeting | 01-Sep-2020 |
| 2 | Annual General Meeting/Dividend - Rs 2 Per Share | 18-Jul-2019 |
| 2 | Annual General Meeting/Dividend- Rs 2 Per Share | 14-Aug-2018 |
| 2 | Annual General Meeting | 19-Sep-2017 |
| 2 | Annual General Meeting/Dividend Re 1/- Per Share | 25-Aug-2016 |
| 2 | Annual General Meeting/Dividend - Re 1/- Per Share | 06-Aug-2015 |
| 2 | Annual General Meeting/Dividend Rs 2/- Per Share | 27-Jun-2014 |
| 2 | Annual General Meeting / Final Dividend Re.0.60/- Per Equity Share | 23-May-2013 |
| 2 | Annual General Meeting | 06-Sep-2012 |
| 2 | Annual General Meeting And Dividend Re.0.40 Per Share | 15-Sep-2011 |
| 2 | Annual General Meeting And Dividend Re.0.80 Per Share | 23-Sep-2010 |
| 2 | Ann Clsng/Dv-Re.0.80 P Sh | 10-Sep-2009 |
| 2 | Agm/Dividend - 40% | 28-Aug-2008 |
| 2 | Agm/Dividend-40% | 02-Aug-2007 |
| 2 | Agm/Dividend-40% | 01-Jun-2006 |
Board Meetings of Vimta Labs Limited
Financial Results of Vimta Labs Limited
Company Directory of Vimta Labs Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.vimta.com | Registered Office | Plot No. 141/ 2 & 142, IDA Phase II, Cherapally, |
HYDERABAD |
| www.vimta.com | Transfer Agent | CIL Securities Ltd 214, Raghava Ratha Towers, Chirag Ali Lane, Abids, |
HYDERABAD |
Insider Trading of Vimta Labs Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | Harriman Vungal | 3142606 | Sell |
| 7(2) | Harriman Vungal | 1012050 | Sell |
| 7(2) | Harriman Vungal | 0 | Sell |
| 7(2) | Sujani Vasireddi | 1537680 | Sell |
| 7(2) | Dhanya Prakash Dhumal | 2221784 | Sell |
| 7(2) | Ravi Kumar Kunuguntla | 1721580 | Sell |
| 7(2) | Sujani Vasireddi | 5797294 | Sell |
| 7(2) | Suresh Kumar S | 1122311 | Sell |
| 7(2) | Dr Muni Nagendra Prasad Poola | 673525 | Sell |
| 7(2) | Suresh Kumar S | 1114993 | Sell |
| 7(2) | D R Narahai Naidu | 2807723 | Sell |
| 7(2) | Sujani Vasireddi | 3844867 | Sell |
| 7(2) | Dr Muni Nagendra Prasad Poola | 1367868 | Sell |
| 7(2) | Sujani Vasireddi | 3525863 | Sell |
| 7(2) | Sujani Vasireddi | 5085607 | Sell |
| 7(2) | Suresh Kumar | 981500 | Sell |
| 7(2) | Sivalinga Prasad Vasireddi | 0 | Sell |
| 7(2) | Praveena Vasireddi | 0 | Buy |
| 7(2) | Sujani Vasireddi | 9617888 | Sell |
| 7(2) | Praveena Vasireddi | 5100000 | Sell |
Annual Reports of Vimta Labs Limited
Investor Complaints of Vimta Labs Limited
Event Calendar of Vimta Labs Limited
| Purpose | Details |
|---|---|
| Results/Dividend | To consider and to take on record the audited financial results for the financial year ended March 31, 2011. Further, the Board, in its above said meeting proposed to consider recommendation of Dividend. |
| Results/Dividend | To consider and to take on record the audited financial results for the financial year ended March 31, 2013. Further the Company has informed that the Board, in its aforesaid meeting proposed to consider recommendation of Dividend. |
| Results | To consider and to take on record the unaudited financial results for the 1st quarter ended June 30, 2013. |
| Results | To consider and to take on record the unaudited financial results for the 2nd quarter ended September 30, 2013. |
| Results | to consider and to take on record the unaudited financial results for the 3rd quarter ended December 31, 2013. |
| Results/Dividend | to consider and to take on record the audited financial results for the financial year ended March 31, 2014 & to consider recommendation of Dividend. |
| Results | to consider and to take on record the unaudited financial results for the 1st quarter ended June 30, 2014. |
| Results | To consider and to take on record the unaudited financial results for the 2nd quarter ended September 30, 2014. |
| Results | to consider and to take on record the unaudited financial results for the 3rd quarter ended December 31, 2014. |
| Results/Dividend | Inter-alia, to consider, approve and take on record the Audited Financial Results for the 4th Quarter and for the Financial year ended March 31, 2015. Further, pursuant to clause 19(a) of the listing agreement it is informed that the Board proposed to consider recommendation of Dividend, if any., |
| Results | to consider and to take on record the unaudited financial results for the 1st quarter ended June 30, 2015. |
| Results | To consider and to take on record the unaudited financial results for the half year ended September 30, 2015. |
| Results | Inter alia, to consider and to take on record the unaudited financial results for the quarter ended December 31, 2015. |
| Results/Dividend | Inter-alia, to consider, approve and take on record the Audited Financial Results for the 4th Quarter and for the Financial year ended March 31, 2016. Further, pursuant to clause 29 (1) (e) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that the Board proposed to consider recommendation of Dividend, if any. |
| Results | Inter-alia, to consider, approve and take on record the Unaudited Financial Results for the 1st Quarter ended June 30, 2016. |
| Results | inter-alia, to consider, approve and take on record the Unaudited Financial Results for the 2nd Quarter ended September 30, 2016. |
| Results | Inter-alia, to consider, approve and take on record the Unaudited Financial Results for the 3rd Quarter ended December 31, 2016. |
| Results/Dividend | inter-alia, to consider, approve and take on record the Audited Financial Results for the 4th Quarter and for the Financial year ended March 31, 2017. Further that the Board proposed to consider recommendation of Dividend, if any in the above said meeting. |
| Results | Sub : inter-alia, to consider, approve and take on record the Unaudited Financial Results for the 1st Quarter ended June 30, 2017 with due implementation of Ind-AS. |
| Results | inter-alia, to consider, approve and take on record the Unaudited Financial Results for the 2nd Quarter ended September 30, 2017. |
| Results | Inter-alia, to consider, approve and take on record the Unaudited Financial Results for the 3rd Quarter ended December 31, 2017.ￂﾠ |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2018 and dividend |
| Financial Results/Dividend | VIMTALABS : 11-May-2018 : The Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on May 10, 2018 To consider and approve the financial results for the period ended March 31, 2018 and dividend. Further, the Company has now informed the Exchange that with the approval of all the Directors of the Company present at their meeting held on May 10, 2018, the Chairman adjourned the meeting for the day. The Board meeting will resume on May 11,2018. |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2018 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2019 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2019 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2020 |
| Financial Results | To consider and approve the standalone unaudited financial results and consolidated unaudited financial results for the period ended Jun 30, 2020 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2020 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2020 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2021 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2021 |
| Financial results | Vimta Labs Limited has informed the Exchange about Board Meeting to be held on 25-Jul-2022 to consider financial statements for the period ended June 2022 |
| Financial results | Vimta Labs Limited has informed the Exchange about Board Meeting to be held on 27-Oct-2022 to consider financial statements for the period ended September 2022 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2022 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2023 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2023 |
| Other business matters | To consider and approve the scheme of amalgamation of Emtac Laboratories Private Limited, Wholly Owned Subsidiary Company with Vimta Labs Limited. |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2024 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
Share Transfers of Vimta Labs Limited
Voting Results of Vimta Labs Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 18-JUL-2024 | AGM | To receive, consider, approve and adopt: (a)the Standalone Audited Financial Statements of the company for the financial year ended 31st March, 2024 together with the reports of the Board of Directors and the Auditors of the company thereon; and (b)the Consolidated Audited Financial Statements of the company for the financial year ended 31st March, 2024 together with the report of the Auditors of the company thereon. |
| 18-JUL-2024 | AGM | Ratification of remuneration of cost auditors for financial year ended 31st March 2025. |
| 18-JUL-2024 | AGM | To appoint a Director in place of Dr. S P Vasireddi (DIN: 00242288) who retires by rotation and being eligible, offered himself for reappointment. Subject to reappointment, the Director shall continue to be the Executive Chairman for the rest of the tenure for which he was appointed as such. |
| 18-JUL-2024 | AGM | To declare a Dividend of Rs. 2/- per equity share for the financial year ended 31.03.2024. |
| 26-MAR-2024 | Postal Ballot | Re-appointment of Mr. Purnachandra Rao Gutta (DIN: 00876934) as an Independent Director of the Company |
| 26-MAR-2024 | Postal Ballot | Re-appointment of Mr. Satya Sreenivas Neerukonda (DIN 00269814) as ￢ﾀﾜExecutive Director￢ﾀﾝ of the Company |
| 26-MAR-2024 | Postal Ballot | Re-appointment of Mr. Harriman Vungal (DIN 00242621) as ￢ﾀﾜExecutive Director ￢ﾀﾓ Operations￢ﾀﾝ of the Company |
| 26-MAR-2024 | Postal Ballot | Re-appointment of Ms. Harita Vasireddi (DIN 00242512) as ￢ﾀﾜManaging Director￢ﾀﾝ of the Company |
| 26-MAR-2024 | Postal Ballot | Re-appointment of Mr. Sanjay Dave (DIN: 08450232) as an Independent Director of the Company |
| 28-JUN-2023 | AGM | To receive, consider and adopt:n(a) the Standalone Audited Financial Statements of the Company for the financial year ended 31st March, 2023, together with the reports of the Board of Directors and the Auditors thereon; andn(b) the Consolidated Audited Financial Statements of the Company for the financial year ended 31st March, 2023, together with the report of the Auditors thereon.n |
| 28-JUN-2023 | AGM | Approval of maximum limit for payment of Remuneration to Ms. Praveena Vasireddi, a related party, holding an Office or Place of Profit in the Company. |
| 28-JUN-2023 | AGM | Approval of maximum limit for payment of Remuneration to Ms. Sudheshna Vungal, a related party, holding an Office or Place of Profit in the Company. |
| 28-JUN-2023 | AGM | Approval of maximum limit for payment of Remuneration to Ms. Sujani Vasireddi, a related party, holding an Office or Place of Profit in the Company. |
| 28-JUN-2023 | AGM | Appointment of Dr. S P Vasireddi (DIN: 00242288) as Executive Chairman of the Company for a period of 3 years. |
| 28-JUN-2023 | AGM | Ratification of remuneration of cost auditors for financial year ending 31st March, 2024. |
| 28-JUN-2023 | AGM | To appoint a Director in place of Shri. Harriman Vungal (DIN: 00242621) who retires by rotation and being eligible, offered himself for reappointment. Subject to reappointment, the Director shall continue to be the Executive Director - Operations for the rest of the tenure for which he was appointed as such. |
| 28-JUN-2023 | AGM | To declare Dividend of Rs. 2/- per equity share for the financial Year ended 31.03.2023. |
| 25-JUN-2022 | AGM | To receive, consider, approve and adopt:n(a) the Standalone Audited Financial Statements of the Company for the financial year ended 31st March, 2022, together with the reports of the Board of Directors and the Auditors thereon; andn(b) the Consolidated Audited Financial Statements of the Company for the financial year ended 31st March, 2022, together with the report of the Auditors thereon |
| 25-JUN-2022 | AGM | To appoint a Director in place of Dr. S P Vasireddi (DIN:00242288) who retires by rotation and being eligible, offers himself for reappointment. |
| 25-JUN-2022 | AGM | To declare Dividend of Rs. 2/- per equity share for the financial Year ended 31.03.2022. |
FAQs on Vimta Labs Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.